首页 > 最新文献

中华预防医学杂志最新文献

英文 中文
[New progress in laboratory detection of respiratory infectious diseases in children]. [儿童呼吸道传染病实验室检测的新进展]。
Q3 Medicine Pub Date : 2024-09-06 DOI: 10.3760/cma.j.cn112150-20231221-00474
K Y Zhu, F Yuan, H O Yang

Respiratory infectious disease has become ahead of all the children's diseases, with the trend of continuously increasing global incidence, antimicrobial resistance and simultaneous infection with multiple pathogens. Diagnosis of this disease is mainly based on clinical symptoms and pathogenic detection. However, there are some differences in clinical manifestations, progression and prognosis between pediatric patients and adults, which prompting clinical diagnosis mainly depending on clinical laboratory test. Therefore, fast, convenient and accurate methods are urgently needed to clarify the type of infectious pathogen and carry out differentiated treatment, and reduce the burden on families and public health-care systems in schools. This article aims to elaborate the laboratory methods of children's respiratory infectious diseases and explore the opportunities and challenges, which can provide ideas for prevention, early screening and diagnosis, prognosis and treatment monitoring.

呼吸道传染病在全球发病率持续上升、抗菌药耐药性和多种病原体同时感染的趋势下,已成为儿童疾病之首。该病的诊断主要依据临床症状和病原体检测。然而,儿童患者的临床表现、病情发展和预后与成人存在一定差异,这促使临床诊断主要依赖于临床实验室检测。因此,亟需快速、便捷、准确的方法来明确感染病原体的类型,并进行分型治疗,减轻家庭和学校公共医疗系统的负担。本文旨在阐述儿童呼吸道传染病的实验室检测方法,探讨机遇与挑战,为儿童呼吸道传染病的预防、早期筛查与诊断、预后与治疗监测提供思路。
{"title":"[New progress in laboratory detection of respiratory infectious diseases in children].","authors":"K Y Zhu, F Yuan, H O Yang","doi":"10.3760/cma.j.cn112150-20231221-00474","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231221-00474","url":null,"abstract":"<p><p>Respiratory infectious disease has become ahead of all the children's diseases, with the trend of continuously increasing global incidence, antimicrobial resistance and simultaneous infection with multiple pathogens. Diagnosis of this disease is mainly based on clinical symptoms and pathogenic detection. However, there are some differences in clinical manifestations, progression and prognosis between pediatric patients and adults, which prompting clinical diagnosis mainly depending on clinical laboratory test. Therefore, fast, convenient and accurate methods are urgently needed to clarify the type of infectious pathogen and carry out differentiated treatment, and reduce the burden on families and public health-care systems in schools. This article aims to elaborate the laboratory methods of children's respiratory infectious diseases and explore the opportunities and challenges, which can provide ideas for prevention, early screening and diagnosis, prognosis and treatment monitoring.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of the status and related factors of vaccination against respiratory diseases among elderly people aged ≥60 in Zhejiang Province]. [浙江省≥60 岁老年人呼吸道疾病疫苗接种现状及相关因素分析]。
Q3 Medicine Pub Date : 2024-09-06 DOI: 10.3760/cma.j.cn112150-20240115-00053
Y W Xu, L L Ding, L X Ye, Y X Sun, Y D Wang, S Y Wang

The objective of this study is to assess the current status of vaccination against respiratory disease among the elderly aged ≥60 and analyze the factors influencing vaccination rates at both service provider and recipient levels in Zhejiang Province. Using a stratified random sampling method, a questionnaire survey was conducted from September 2022 to January 2023 among elderly people aged ≥60 in 30 townships/streets in Zhejiang Province, as well as immunization planning staff at the provincial, municipal, county/district, and township/street levels. Logistic regression models were used to analyze the factors related to vaccination among elderly people in Zhejiang Province. Based on the Zhejiang Provincial Comprehensive Management Information System for Vaccine and Vaccination, the systematic coverage rates of influenza vaccine and pneumonia vaccine for the elderly were 21.76% and 4.57%, respectively. Multivariate logistic regression analysis indicated that advanced age (OR=1.74, 95%CI: 1.51-1.99), knowing that influenza is more severe than the common cold (OR=1.67, 95%CI: 1.37-2.04) and having heard of the influenza vaccine (OR=9.78, 95%CI: 7.03-13.59) were motivating factors for elderly to receive influenza vaccines. Advanced age (OR=1.71, 95%CI: 1.43-2.06), knowing the serious consequences of pneumonia in the elderly (OR=1.93, 95%CI: 1.47-2.55) and knowing that pneumonia vaccines can prevent pneumonia (OR=6.36, 95%CI: 4.84-8.36) were motivating factors for elderly to receive pneumonia vaccines. Zhejiang Immunization Program staff believed that the main reasons why the elderly aged ≥60 would not be vaccinated against influenza or pneumonia were that they felt they would not get sick (55.52% and 56.35% respectively), it would not be serious if get sick (47.73% and 37.46% respectively), lacking trust in vaccine efficacy and safety (38.31% and 43.69% respectively). Vaccination rates for influenza and pneumonia vaccines among the elderly aged ≥60 in Zhejiang Province are suboptimal. Advanced age, awareness of the severity of respiratory diseases and awareness of vaccines against such diseases are related factors for elderly individuals to receive influenza and pneumonia vaccines.

本研究旨在评估浙江省≥60 岁老年人接种呼吸道疾病疫苗的现状,并从服务提供者和接种者两个层面分析影响接种率的因素。采用分层随机抽样方法,于2022年9月至2023年1月对浙江省30个乡镇/街道的≥60岁老年人以及省、市、县/区、乡镇/街道四级免疫规划工作人员进行了问卷调查。采用逻辑回归模型分析浙江省老年人接种疫苗的相关因素。根据浙江省疫苗和预防接种综合管理信息系统,老年人流感疫苗和肺炎疫苗的系统覆盖率分别为 21.76% 和 4.57%。多变量逻辑回归分析表明,高龄(OR=1.74,95%CI:1.51-1.99)、知道流感比普通感冒更严重(OR=1.67,95%CI:1.37-2.04)和听说过流感疫苗(OR=9.78,95%CI:7.03-13.59)是促使老年人接种流感疫苗的因素。高龄(OR=1.71,95%CI:1.43-2.06)、知道老年人肺炎的严重后果(OR=1.93,95%CI:1.47-2.55)和知道肺炎疫苗可以预防肺炎(OR=6.36,95%CI:4.84-8.36)是老年人接种肺炎疫苗的动机因素。浙江省免疫规划工作人员认为,≥60 岁的老年人不接种流感疫苗和肺炎疫苗的主要原因是他们认为自己不会生病(分别为 55.52% 和 56.35%),生病也不会很严重(分别为 47.73% 和 37.46%),对疫苗的有效性和安全性缺乏信任(分别为 38.31% 和 43.69%)。浙江省≥60 岁老年人的流感和肺炎疫苗接种率不理想。高龄、对呼吸道疾病严重性的认识以及对此类疾病疫苗的认识是老年人接种流感和肺炎疫苗的相关因素。
{"title":"[Analysis of the status and related factors of vaccination against respiratory diseases among elderly people aged ≥60 in Zhejiang Province].","authors":"Y W Xu, L L Ding, L X Ye, Y X Sun, Y D Wang, S Y Wang","doi":"10.3760/cma.j.cn112150-20240115-00053","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240115-00053","url":null,"abstract":"<p><p>The objective of this study is to assess the current status of vaccination against respiratory disease among the elderly aged ≥60 and analyze the factors influencing vaccination rates at both service provider and recipient levels in Zhejiang Province. Using a stratified random sampling method, a questionnaire survey was conducted from September 2022 to January 2023 among elderly people aged ≥60 in 30 townships/streets in Zhejiang Province, as well as immunization planning staff at the provincial, municipal, county/district, and township/street levels. Logistic regression models were used to analyze the factors related to vaccination among elderly people in Zhejiang Province. Based on the Zhejiang Provincial Comprehensive Management Information System for Vaccine and Vaccination, the systematic coverage rates of influenza vaccine and pneumonia vaccine for the elderly were 21.76% and 4.57%, respectively. Multivariate logistic regression analysis indicated that advanced age (<i>OR</i>=1.74, 95%<i>CI:</i> 1.51-1.99), knowing that influenza is more severe than the common cold (<i>OR</i>=1.67, 95%<i>CI</i>: 1.37-2.04) and having heard of the influenza vaccine (<i>OR</i>=9.78, 95%<i>CI</i>: 7.03-13.59) were motivating factors for elderly to receive influenza vaccines. Advanced age (<i>OR</i>=1.71, 95%<i>CI:</i> 1.43-2.06), knowing the serious consequences of pneumonia in the elderly (<i>OR</i>=1.93, 95%<i>CI</i>: 1.47-2.55) and knowing that pneumonia vaccines can prevent pneumonia (<i>OR</i>=6.36, 95%<i>CI</i>: 4.84-8.36) were motivating factors for elderly to receive pneumonia vaccines. Zhejiang Immunization Program staff believed that the main reasons why the elderly aged ≥60 would not be vaccinated against influenza or pneumonia were that they felt they would not get sick (55.52% and 56.35% respectively), it would not be serious if get sick (47.73% and 37.46% respectively), lacking trust in vaccine efficacy and safety (38.31% and 43.69% respectively). Vaccination rates for influenza and pneumonia vaccines among the elderly aged ≥60 in Zhejiang Province are suboptimal. Advanced age, awareness of the severity of respiratory diseases and awareness of vaccines against such diseases are related factors for elderly individuals to receive influenza and pneumonia vaccines.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prevalence and associated factors of diabetic retinopathy among type 2 diabetes in Dongcheng District and Tongzhou District, Beijing City: a cross-sectional study]. [北京市东城区和通州区 2 型糖尿病患者糖尿病视网膜病变的患病率及相关因素:一项横断面研究]。
Q3 Medicine Pub Date : 2024-09-06 DOI: 10.3760/cma.j.cn112150-20240222-00136
X R Zhu, F Y Yang, L Zhang, R R Xie, J P Feng, Z Xin, W Tian

Objective: Diabetic retinopathy (DR) is the most common cause of adult blindness in China. Screening of DR is important for early detection, prevention, and treatment. However, there is still controversy in the research on the prevalence and risk factors of DR in China. This study was designed to evaluate the prevalence of DR and related risk factors in patients with type 2 diabetes mellitus in Beijing City. Methods: A cross-sectional survey was conducted in in Dongcheng District and Tongzhou District, Beijing City. Patients with type 2 diabetes aged 18-80 years were selected from four communities, and all subjects underwent questionnaires, physical examinations, laboratory examinations and fundus photography. The logistic regression model was used to analyze the associated factors of DR. Results: A total of 1 531 subjects were included, with the median age of 66 years old and the average age of (65.6±7.4) years old, and the glycosylated hemoglobin level in the subjects was 7.2%±1.3%, and the glycosylated hemoglobin compliance rate was 56.0%(857/1 531). A total of 254 patients with diabetic retinopathy were detected, and the prevalence of DR was 16.6%(254/1 531). Among them, there were 218 cases of non-proliferative diabetic retinopathy and 36 cases of proliferative diabetic retinopathy. Compared with the non-DR group, there were statistically significant differences in fasting blood glucose (Z=-3.74, P<0.001), glycosylated hemoglobin(Z=-10.664, P<0.001), urinary microalbumin excretion rate(Z=-7.767,P<0.001), low-density lipoprotein cholesterol(Z=-2.589, P=0.01), and duration of diabetes(Z=-10.189, P<0.001) between the DR group and the non-DR group. Multivariate regression analysis showed that the duration of diabetes (OR=1.08, 95%CI: 1.06-1.10, P<0.001), glycosylated hemoglobin (OR=1.38, 95%CI: 1.23-1.55, P<0.001), and FPG (OR=1.11, 95%CI: 1.03-1.19, P=0.008) were associated factors for DR. Conclusion: In this study, the prevalence of DR in 4 communities of type 2 diabetes in Beijing City was 16.6%. Besides, this study further confirmed that the duration of diabetes, fasting blood glucose levels, and glycosylated hemoglobin are associated factors for DR in patients with type 2 diabetes.

目的:糖尿病视网膜病变(DR)是中国成人失明的最常见原因。糖尿病视网膜病变筛查对于早期发现、预防和治疗具有重要意义。然而,关于中国糖尿病视网膜病变的患病率和风险因素的研究仍存在争议。本研究旨在评估北京市 2 型糖尿病患者中 DR 的患病率及相关风险因素。研究方法在北京市东城区和通州区进行横断面调查。所有受试者均接受了问卷调查、体格检查、实验室检查和眼底照相。采用逻辑回归模型分析 DR 的相关因素。结果:共纳入 1 531 名受试者,中位年龄为 66 岁,平均年龄为(65.6±7.4)岁,受试者的糖化血红蛋白水平为 7.2%±1.3%,糖化血红蛋白达标率为 56.0%(857/1 531)。共发现 254 例糖尿病视网膜病变患者,DR 患病率为 16.6%(254/1 531)。其中,非增殖性糖尿病视网膜病变 218 例,增殖性糖尿病视网膜病变 36 例。与非 DR 组相比,空腹血糖(Z=-3.74,PZ=-10.664,PZ=-7.767,PZ=-2.589,P=0.01)和糖尿病病程(Z=-10.189,POR=1.08,95%CI:1.06-1.10,POR=1.38,95%CI:1.23-1.55,POR=1.11,95%CI:1.03-1.19,P=0.008)是 DR 的相关因素,差异有统计学意义。结论在本研究中,北京市 4 个 2 型糖尿病社区的 DR 患病率为 16.6%。此外,本研究进一步证实,糖尿病病程、空腹血糖水平和糖化血红蛋白是 2 型糖尿病患者 DR 的相关因素。
{"title":"[Prevalence and associated factors of diabetic retinopathy among type 2 diabetes in Dongcheng District and Tongzhou District, Beijing City: a cross-sectional study].","authors":"X R Zhu, F Y Yang, L Zhang, R R Xie, J P Feng, Z Xin, W Tian","doi":"10.3760/cma.j.cn112150-20240222-00136","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240222-00136","url":null,"abstract":"<p><p><b>Objective:</b> Diabetic retinopathy (DR) is the most common cause of adult blindness in China. Screening of DR is important for early detection, prevention, and treatment. However, there is still controversy in the research on the prevalence and risk factors of DR in China. This study was designed to evaluate the prevalence of DR and related risk factors in patients with type 2 diabetes mellitus in Beijing City. <b>Methods:</b> A cross-sectional survey was conducted in in Dongcheng District and Tongzhou District, Beijing City. Patients with type 2 diabetes aged 18-80 years were selected from four communities, and all subjects underwent questionnaires, physical examinations, laboratory examinations and fundus photography. The logistic regression model was used to analyze the associated factors of DR. <b>Results:</b> A total of 1 531 subjects were included, with the median age of 66 years old and the average age of (65.6±7.4) years old, and the glycosylated hemoglobin level in the subjects was 7.2%±1.3%, and the glycosylated hemoglobin compliance rate was 56.0%(857/1 531). A total of 254 patients with diabetic retinopathy were detected, and the prevalence of DR was 16.6%(254/1 531). Among them, there were 218 cases of non-proliferative diabetic retinopathy and 36 cases of proliferative diabetic retinopathy. Compared with the non-DR group, there were statistically significant differences in fasting blood glucose (<i>Z=</i>-3.74, <i>P</i><0.001), glycosylated hemoglobin(<i>Z</i>=-10.664, <i>P</i><0.001), urinary microalbumin excretion rate(<i>Z</i>=-7.767,<i>P</i><0.001), low-density lipoprotein cholesterol(<i>Z</i>=-2.589, <i>P</i>=0.01), and duration of diabetes(<i>Z</i>=-10.189, <i>P</i><0.001) between the DR group and the non-DR group. Multivariate regression analysis showed that the duration of diabetes (<i>OR</i>=1.08, 95%<i>CI</i>: 1.06-1.10, <i>P</i><0.001), glycosylated hemoglobin (<i>OR</i>=1.38, 95%<i>CI</i>: 1.23-1.55, <i>P</i><0.001), and FPG (<i>OR</i>=1.11, 95%<i>CI</i>: 1.03-1.19, <i>P</i>=0.008) were associated factors for DR. <b>Conclusion:</b> In this study, the prevalence of DR in 4 communities of type 2 diabetes in Beijing City was 16.6%. Besides, this study further confirmed that the duration of diabetes, fasting blood glucose levels, and glycosylated hemoglobin are associated factors for DR in patients with type 2 diabetes.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Expert recommendations on the implementation and evaluation of free influenza vaccination project in the elderly]. [关于实施和评估老年人免费流感疫苗接种项目的专家建议]。
Q3 Medicine Pub Date : 2024-09-06 DOI: 10.3760/cma.j.cn112150-20231226-00495

Influenza places a substantial burden on the elderly population. Implementation of free influenza vaccination project can significantly improve the influenza vaccination rate in the elderly, and reduce influenza incidence, hospitalization, and death. With the implementation of the project, rich experience has been accumulated in various localities. To provide guidance for scientific implementation and evaluation of the free influenza vaccination project in other regions, the expert group formulated recommendations for the implementation and evaluation of the project. The recommendations focus on project application and approval, project organization and implementation, and project evaluation, in which the vaccination rate, vaccine effectiveness, satisfaction, safety, health economics, and health benefits are evaluated.

流感给老年人群带来沉重负担。实施免费流感疫苗接种项目可显著提高老年人流感疫苗接种率,降低流感发病率、住院率和死亡率。随着项目的实施,各地积累了丰富的经验。为指导其他地区科学实施和评估免费流感疫苗接种项目,专家组制定了项目实施和评估建议。建议主要从项目申请与审批、项目组织与实施、项目评估等方面对项目的接种率、接种效果、满意度、安全性、卫生经济性、卫生效益等进行评估。
{"title":"[Expert recommendations on the implementation and evaluation of free influenza vaccination project in the elderly].","authors":"","doi":"10.3760/cma.j.cn112150-20231226-00495","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231226-00495","url":null,"abstract":"<p><p>Influenza places a substantial burden on the elderly population. Implementation of free influenza vaccination project can significantly improve the influenza vaccination rate in the elderly, and reduce influenza incidence, hospitalization, and death. With the implementation of the project, rich experience has been accumulated in various localities. To provide guidance for scientific implementation and evaluation of the free influenza vaccination project in other regions, the expert group formulated recommendations for the implementation and evaluation of the project. The recommendations focus on project application and approval, project organization and implementation, and project evaluation, in which the vaccination rate, vaccine effectiveness, satisfaction, safety, health economics, and health benefits are evaluated.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Immune-mediated neuropathies: pathophysiology and management]. [免疫介导的神经病变:病理生理学和管理]。
Q3 Medicine Pub Date : 2024-09-06 DOI: 10.3760/cma.j.cn112150-20231220-00473
Y Y Tian, P P Yuan, X G Wang

Immune-mediated neuropathies (IMN) are a heterogenous group of disorders affecting the peripheral nervous system, due to dysregulation of the immune system. It mainly includes Guillain-Barre syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy and so on. Most of these diseases can be clinically improved by appropriate immunotherapy, but some patients still have unsatisfactory results. Therefore, studying the pathophysiology of the occurrence and development of diseases can reveal the nature of diseases and provide a theoretical basis for the prevention, diagnosis and treatment of diseases. In this paper, the pathophysiological mechanism of various IMNs is described in detail, with emphasis on immunological mechanism, and the progress of diagnosis and treatment of various IMNs is briefly introduced.

免疫介导的神经病(IMN)是一组由于免疫系统失调而影响周围神经系统的异质性疾病。它主要包括格林-巴利综合征、慢性炎症性脱髓鞘多发性神经病、多灶性运动神经病等。这些疾病大多可以通过适当的免疫治疗得到临床改善,但仍有部分患者疗效不理想。因此,研究疾病发生、发展的病理生理学,可以揭示疾病的本质,为疾病的预防、诊断和治疗提供理论依据。本文以免疫学机制为重点,详细阐述了各种 IMN 的病理生理学机制,并简要介绍了各种 IMN 的诊断和治疗进展。
{"title":"[Immune-mediated neuropathies: pathophysiology and management].","authors":"Y Y Tian, P P Yuan, X G Wang","doi":"10.3760/cma.j.cn112150-20231220-00473","DOIUrl":"10.3760/cma.j.cn112150-20231220-00473","url":null,"abstract":"<p><p>Immune-mediated neuropathies (IMN) are a heterogenous group of disorders affecting the peripheral nervous system, due to dysregulation of the immune system. It mainly includes Guillain-Barre syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy and so on. Most of these diseases can be clinically improved by appropriate immunotherapy, but some patients still have unsatisfactory results. Therefore, studying the pathophysiology of the occurrence and development of diseases can reveal the nature of diseases and provide a theoretical basis for the prevention, diagnosis and treatment of diseases. In this paper, the pathophysiological mechanism of various IMNs is described in detail, with emphasis on immunological mechanism, and the progress of diagnosis and treatment of various IMNs is briefly introduced.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress of follistatin-related proteins in digestive system tumors]. [消化系统肿瘤中软骨素相关蛋白的研究进展]。
Q3 Medicine Pub Date : 2024-09-06 DOI: 10.3760/cma.j.cn112150-20240529-00436
J N Wu, Y Z Jiang

Tumors of the digestive system are one of the most important factors affecting people's quality of life and have become a serious public health problem globally.Early screening and intervention of tumor markers in high-risk groups for tumors is the key to tumor prevention. Follistatin-related proteins (FRP) are important members of the follistatin family and such proteins are involved in the pathological process of tumors of the reproductive system and respiratory system, among others. In recent years, FRP has attracted extensive attention in the study of digestive system tumors, suggesting that FRP may play a significant role in the development of digestive system tumors, and is a potential marker for clinical diagnosis and treatment. The article reviews the biological function, expression and potential mechanism of action of FRP associated with digestive system tumors, with a view to providing reference for the diagnosis and prevention of digestive system tumors, prognosis assessment and drug development.

消化系统肿瘤是影响人们生活质量的最重要因素之一,已成为全球严重的公共卫生问题。对肿瘤高危人群进行肿瘤标志物的早期筛查和干预是预防肿瘤的关键。绒毛膜促性腺激素相关蛋白(FRP)是绒毛膜促性腺激素家族的重要成员,此类蛋白参与了生殖系统和呼吸系统等肿瘤的病理过程。近年来,FRP在消化系统肿瘤的研究中引起了广泛关注,提示FRP可能在消化系统肿瘤的发生发展中起着重要作用,是临床诊断和治疗的潜在标志物。文章综述了与消化系统肿瘤相关的 FRP 的生物学功能、表达及潜在作用机制,以期为消化系统肿瘤的诊断和预防、预后评估及药物开发提供参考。
{"title":"[Research progress of follistatin-related proteins in digestive system tumors].","authors":"J N Wu, Y Z Jiang","doi":"10.3760/cma.j.cn112150-20240529-00436","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240529-00436","url":null,"abstract":"<p><p>Tumors of the digestive system are one of the most important factors affecting people's quality of life and have become a serious public health problem globally.Early screening and intervention of tumor markers in high-risk groups for tumors is the key to tumor prevention. Follistatin-related proteins (FRP) are important members of the follistatin family and such proteins are involved in the pathological process of tumors of the reproductive system and respiratory system, among others. In recent years, FRP has attracted extensive attention in the study of digestive system tumors, suggesting that FRP may play a significant role in the development of digestive system tumors, and is a potential marker for clinical diagnosis and treatment. The article reviews the biological function, expression and potential mechanism of action of FRP associated with digestive system tumors, with a view to providing reference for the diagnosis and prevention of digestive system tumors, prognosis assessment and drug development.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of the effectiveness of cross-reactive carbohydrate antigen determinant antibody adsorbents in identifying allergen-specific IgE antibodies]. [交叉反应碳水化合物抗原决定簇抗体吸附剂在鉴定过敏原特异性 IgE 抗体中的有效性分析]。
Q3 Medicine Pub Date : 2024-09-06 DOI: 10.3760/cma.j.cn112150-20240615-00475
W L Zhao, B Cai, C Q Shi, Z Z Su, W H Feng

This study aimed to investigate the influence of anti-cross-reactive carbohydrate determinant IgE antibodies (anti-CCD IgE) on the detection of allergen-specific IgE (sIgE) antibodies, as well as the application value of anti-CCD IgE adsorbents in detecting allergen sIgE. In this cross-sectional study, a total of 2 636 test samples from patients who received treatment in West China Hospital of Sichuan University and tested allergen sIgE using the western blot method from October 2020 to May 2021 were analyzed. In these samples, 709 samples tested postive of allergen sIgE. 46 stochastic venous serum samples that tested positive in both sIgE and anti-CCD IgE and 1 serum sample that tested positive in sIgE but negative in anti-CCD IgE were collected. These samples were processed by anti-CCD IgE adsorbents, followed by allergen sIgE detection. The difference between the two detection results before and after adsorption was analyzed. The allergen test results showed that the positive rate of anti-CCD IgE in samples was 2.6% (69/2 636) during the period of sample collection. After treatment with anti-CCD IgE adsorbents, the top three allergen-sIgE of the positive rate changed from tree combination 2 (willow/poplar/elm), common ragweed and peanut to dust mite combination, cockroach and crab. The positive anti-CCD IgE results of 46 samples all turned negative and the total positive sIgE antibody dropped by 62.8%; the positive rate of sIgE antibodies with the class result ≥2 significantly decreased after treatment with anti-CCD IgE adsorbents, especially the positive rate of common ragweed dropped by 96.2%. The results of positive samples showed that multiple sIgE antibodies declined by different ranges, involving up to 11 antibodies with a maximum decline of 4 classes. Strongly positive sIgE antibodies (the class result ≥4) also had a high conversion rate of negative (25.0%-100%). The positive sIgE antibodies in about 60% of the samples decreased by more than 2, and the sIgE antibodies in 17.4% of the samples turned completely negative. There was no change in the allergen sIgE detection results of the sample with negative anti-CCD IgE after treatment. In conclusion, sIgE antibodies including targeting common ragweed, humulus, tree combination 2 (willow/poplar/elm), etc. are susceptible to false positives caused by anti-CCD IgE. Treatment of samples with anti-CCD IgE adsorbents can significantly reduce the risk of false positives caused by anti-CCD IgE. It is necessary to pretreat samples that were anti-CCD IgE positive with anti-CCD IgE adsorbents, which can make laboratory results more accurate and provide a reference for diagnosis and prevention of allergic diseases.

本研究旨在探讨抗交叉反应性碳水化合物决定簇IgE抗体(抗CCD IgE)对过敏原特异性IgE(sIgE)抗体检测的影响,以及抗CCD IgE吸附剂在检测过敏原sIgE中的应用价值。在这项横断面研究中,我们分析了2020年10月至2021年5月期间在四川大学华西医院接受治疗并使用Western印迹法检测过敏原sIgE的患者的2 636份检测样本。在这些样本中,709 份样本的过敏原 sIgE 检测呈阳性。此外,还收集了 46 份随机静脉血清样本(sIgE 和抗CCD IgE 均呈阳性)和 1 份血清样本(sIgE 呈阳性,抗CCD IgE 呈阴性)。这些样本经抗CCD IgE 吸附剂处理后,再进行过敏原 sIgE 检测。分析了吸附前后两次检测结果的差异。过敏原检测结果表明,在样本采集期间,样本中的抗CCD IgE 阳性率为 2.6%(69/2 636)。经抗CCD IgE 吸附剂处理后,阳性率前三位的过敏原-SIgE 由树木组合 2(柳树/杨树/榆树)、普通豚草和花生变为尘螨组合、蟑螂和螃蟹。46 份样本的抗 CD IgE 阳性结果全部转阴,sIgE 抗体总阳性率下降了 62.8%;经抗 CD IgE 吸附剂处理后,sIgE 抗体≥2 级的阳性率明显下降,尤其是普通豚草的阳性率下降了 96.2%。阳性样本的结果显示,多种 sIgE 抗体的下降幅度不同,最多涉及 11 种抗体,最大下降幅度为 4 级。强阳性 sIgE 抗体(结果≥4 级)的阴转率也很高(25.0%-100%)。约 60% 样本的 sIgE 阳性抗体下降超过 2,17.4% 样本的 sIgE 抗体完全转阴。抗CCD IgE 阴性样本的过敏原 sIgE 检测结果在治疗后没有变化。总之,针对普通豚草、葎草、树木组合 2(柳树/杨树/榆树)等的 sIgE 抗体容易受到抗CCD IgE 的影响而出现假阳性。用抗滴滴涕 IgE 吸附剂处理样本可大大降低抗滴滴涕 IgE 造成假阳性的风险。因此,有必要用抗-CDD IgE 吸附剂对抗-CDD IgE 阳性的样本进行预处理,使实验室结果更加准确,为过敏性疾病的诊断和预防提供参考。
{"title":"[Analysis of the effectiveness of cross-reactive carbohydrate antigen determinant antibody adsorbents in identifying allergen-specific IgE antibodies].","authors":"W L Zhao, B Cai, C Q Shi, Z Z Su, W H Feng","doi":"10.3760/cma.j.cn112150-20240615-00475","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240615-00475","url":null,"abstract":"<p><p>This study aimed to investigate the influence of anti-cross-reactive carbohydrate determinant IgE antibodies (anti-CCD IgE) on the detection of allergen-specific IgE (sIgE) antibodies, as well as the application value of anti-CCD IgE adsorbents in detecting allergen sIgE. In this cross-sectional study, a total of 2 636 test samples from patients who received treatment in West China Hospital of Sichuan University and tested allergen sIgE using the western blot method from October 2020 to May 2021 were analyzed. In these samples, 709 samples tested postive of allergen sIgE. 46 stochastic venous serum samples that tested positive in both sIgE and anti-CCD IgE and 1 serum sample that tested positive in sIgE but negative in anti-CCD IgE were collected. These samples were processed by anti-CCD IgE adsorbents, followed by allergen sIgE detection. The difference between the two detection results before and after adsorption was analyzed. The allergen test results showed that the positive rate of anti-CCD IgE in samples was 2.6% (69/2 636) during the period of sample collection. After treatment with anti-CCD IgE adsorbents, the top three allergen-sIgE of the positive rate changed from tree combination 2 (willow/poplar/elm), common ragweed and peanut to dust mite combination, cockroach and crab. The positive anti-CCD IgE results of 46 samples all turned negative and the total positive sIgE antibody dropped by 62.8%; the positive rate of sIgE antibodies with the class result ≥2 significantly decreased after treatment with anti-CCD IgE adsorbents, especially the positive rate of common ragweed dropped by 96.2%. The results of positive samples showed that multiple sIgE antibodies declined by different ranges, involving up to 11 antibodies with a maximum decline of 4 classes. Strongly positive sIgE antibodies (the class result ≥4) also had a high conversion rate of negative (25.0%-100%). The positive sIgE antibodies in about 60% of the samples decreased by more than 2, and the sIgE antibodies in 17.4% of the samples turned completely negative. There was no change in the allergen sIgE detection results of the sample with negative anti-CCD IgE after treatment. In conclusion, sIgE antibodies including targeting common ragweed, humulus, tree combination 2 (willow/poplar/elm), etc. are susceptible to false positives caused by anti-CCD IgE. Treatment of samples with anti-CCD IgE adsorbents can significantly reduce the risk of false positives caused by anti-CCD IgE. It is necessary to pretreat samples that were anti-CCD IgE positive with anti-CCD IgE adsorbents, which can make laboratory results more accurate and provide a reference for diagnosis and prevention of allergic diseases.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Discussion on aesthetic and chemical characteristics of drinking water quality in emergencies]. [讨论紧急情况下饮用水水质的美学和化学特征]。
Q3 Medicine Pub Date : 2024-09-06 DOI: 10.3760/cma.j.cn112150-20231124-00373
Y Yu, J Fei, Z Ding, H Zheng

The Standards for drinking water quality(GB 5749-2022), which has taken effect on April 1, 2023, stipulates that limit values of aesthetic and chemical characteristics of drinking water can be temporarily adjusted in emergencies. However, the national standard does not clearly specify the adjusted period and limit values. This study is based on the principle that the human body will not cause acute toxic damage during short-term exposure, considering the acceptability such as chromaticity, smell, and taste in drinking water, referring to the drinking water quality standards of different countries and regions including the World Health Organization, the United States, the European Union, Japan, Australia, etc. We discussed the limited values during emergencies for 21 aesthetic and chemical characteristics from GB 5749-2022 to guaranine the drinking water safety and human health in emergencies.

已于 2023 年 4 月 1 日开始实施的《生活饮用水水质标准》(GB 5749-2022)规定,在紧急情况下可临时调整饮用水的卫生学和化学指标限值。但国家标准并未明确规定调整期限和限值。本研究以短期接触不会对人体造成急性毒性损害为原则,考虑饮用水的色度、气味、口感等可接受性,参考了世界卫生组织、美国、欧盟、日本、澳大利亚等不同国家和地区的饮用水水质标准。我们讨论了 GB 5749-2022 中 21 种美学和化学特征在紧急情况下的限值,以确保紧急情况下的饮用水安全和人类健康。
{"title":"[Discussion on aesthetic and chemical characteristics of drinking water quality in emergencies].","authors":"Y Yu, J Fei, Z Ding, H Zheng","doi":"10.3760/cma.j.cn112150-20231124-00373","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231124-00373","url":null,"abstract":"<p><p>The Standards for drinking water quality(GB 5749-2022), which has taken effect on April 1, 2023, stipulates that limit values of aesthetic and chemical characteristics of drinking water can be temporarily adjusted in emergencies. However, the national standard does not clearly specify the adjusted period and limit values. This study is based on the principle that the human body will not cause acute toxic damage during short-term exposure, considering the acceptability such as chromaticity, smell, and taste in drinking water, referring to the drinking water quality standards of different countries and regions including the World Health Organization, the United States, the European Union, Japan, Australia, etc. We discussed the limited values during emergencies for 21 aesthetic and chemical characteristics from GB 5749-2022 to guaranine the drinking water safety and human health in emergencies.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Component-resolved diagnosis: enhancing precision diagnosis and clinical management of shellfish allergies]. [成分解析诊断:提高贝类过敏的精确诊断和临床管理]。
Q3 Medicine Pub Date : 2024-09-06 DOI: 10.3760/cma.j.cn112150-20240613-00470
J L Zhang, W T Luo, A L Li, B Q Sun

Shellfish, being one of the eight major food allergens, affects approximately 3% of the global population. The occurrence of shellfish allergy is not only related to the individual's immune system sensitivity but is also influenced by geographical environment, food availability, and dietary habits. Although crustaceans (such as shrimp, crab, and lobster) and mollusks (such as oysters, mussels, and squid) are collectively referred to as shellfish, they exhibit significant differences in biological evolution and the spectrum of allergenic molecules they contain, leading to various allergic reactions. Accurate identification of allergenic proteins is crucial for the diagnosis and management of shellfish allergies, with key allergenic protein families including tropomyosin, arginine kinase, and hemocyanin. Furthermore, due to the diversity of shellfish allergens and their cross-reactivity with dust mite and insect allergens, diagnosing and managing shellfish allergies is complex, especially concerning tropomyosin and arginine kinase protein families. Currently, there are no specific immunotherapy treatments for shellfish allergies, and clinical management primarily relies on avoiding allergens and using anti-allergy medications. This article thoroughly interprets the " Molecular Allergology User's Guide 2.0 (MAUG 2.0)" published by the European Academy of Allergy and Clinical Immunology (EAACI) and the latest research on shellfish allergies both domestically and internationally. It highlights the significant role of allergen component diagnostics in optimizing the diagnostic and treatment processes for shellfish allergies, effectively assisting clinicians in accurately identifying common allergens and cross-reactions, thereby providing patients with more personalized diagnosis and treatment plans.

贝类是八大食物过敏原之一,全球约有 3% 的人对其过敏。贝类过敏的发生不仅与个人免疫系统的敏感性有关,还受到地理环境、食物供应和饮食习惯的影响。虽然甲壳类(如虾、蟹和龙虾)和软体类(如牡蛎、贻贝和鱿鱼)统称为贝类,但它们在生物进化和所含过敏原分子谱方面存在显著差异,从而导致各种过敏反应。准确鉴定过敏原蛋白对于贝类过敏的诊断和治疗至关重要,主要的过敏原蛋白家族包括肌球蛋白、精氨酸激酶和血蓝蛋白。此外,由于贝类过敏原的多样性及其与尘螨和昆虫过敏原的交叉反应性,诊断和治疗贝类过敏非常复杂,尤其是肌球蛋白和精氨酸激酶蛋白家族。目前,贝类过敏还没有特定的免疫疗法,临床治疗主要依靠避免接触过敏原和使用抗过敏药物。本文全面解读了欧洲过敏与临床免疫学学会(EAACI)发布的《分子过敏学用户指南 2.0》(MAUG 2.0)以及国内外有关贝类过敏的最新研究。它强调了过敏原成分诊断在优化贝类过敏诊断和治疗过程中的重要作用,可有效协助临床医生准确识别常见过敏原和交叉反应,从而为患者提供更个性化的诊断和治疗方案。
{"title":"[Component-resolved diagnosis: enhancing precision diagnosis and clinical management of shellfish allergies].","authors":"J L Zhang, W T Luo, A L Li, B Q Sun","doi":"10.3760/cma.j.cn112150-20240613-00470","DOIUrl":"10.3760/cma.j.cn112150-20240613-00470","url":null,"abstract":"<p><p>Shellfish, being one of the eight major food allergens, affects approximately 3% of the global population. The occurrence of shellfish allergy is not only related to the individual's immune system sensitivity but is also influenced by geographical environment, food availability, and dietary habits. Although crustaceans (such as shrimp, crab, and lobster) and mollusks (such as oysters, mussels, and squid) are collectively referred to as shellfish, they exhibit significant differences in biological evolution and the spectrum of allergenic molecules they contain, leading to various allergic reactions. Accurate identification of allergenic proteins is crucial for the diagnosis and management of shellfish allergies, with key allergenic protein families including tropomyosin, arginine kinase, and hemocyanin. Furthermore, due to the diversity of shellfish allergens and their cross-reactivity with dust mite and insect allergens, diagnosing and managing shellfish allergies is complex, especially concerning tropomyosin and arginine kinase protein families. Currently, there are no specific immunotherapy treatments for shellfish allergies, and clinical management primarily relies on avoiding allergens and using anti-allergy medications. This article thoroughly interprets the \" Molecular Allergology User's Guide 2.0 (MAUG 2.0)\" published by the European Academy of Allergy and Clinical Immunology (EAACI) and the latest research on shellfish allergies both domestically and internationally. It highlights the significant role of allergen component diagnostics in optimizing the diagnostic and treatment processes for shellfish allergies, effectively assisting clinicians in accurately identifying common allergens and cross-reactions, thereby providing patients with more personalized diagnosis and treatment plans.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The application and reflection of emerging molecular detection technologies in Salmonella detection]. [新兴分子检测技术在沙门氏菌检测中的应用与思考]。
Q3 Medicine Pub Date : 2024-09-06 DOI: 10.3760/cma.j.cn112150-20240227-00155
L L Xiao, Y L Long, X J Qin, X Wang, Q L Dong

Salmonella is an important foodborne pathogen and one of the main causes of diarrhea. Every year, about 550 million people suffer from diarrhea due to Salmonella infection, of which about 230 000 die. It has become a major global public safety issue. The application fields of Salmonella detection involve food safety, water quality monitoring, animal husbandry, public health monitoring, and medical diagnosis. The detection requirements mainly come from three aspects: pathogen identification, serotype identification, drug resistance and virulence identification. In recent years, the detection technology for Salmonella has made rapid progress, especially the emergence and development of emerging molecular detection technologies, providing new perspectives for Salmonella detection in different scenarios. However, due to the diversity of Salmonella serotypes and the complexity of detection scenarios, existing detection technologies still have some pain points (such as long detection time, cumbersome operation steps, low scene adaptability, etc.). This article will elaborate on the application of several emerging molecular detection technologies with distinct characteristics, such as CRISPR Cas technology, digital PCR technology, sequencing technology, and microfluidic technology, in Salmonella detection. It aims to provide a reference for the development and improvement of Salmonella detection technology and the establishment of infection warning and control systems.

沙门氏菌是一种重要的食源性病原体,也是导致腹泻的主要原因之一。每年约有 5.5 亿人因感染沙门氏菌而腹泻,其中约 23 万人死亡。这已成为一个重大的全球公共安全问题。沙门氏菌检测的应用领域涉及食品安全、水质监测、畜牧业、公共卫生监测和医学诊断。检测要求主要来自三个方面:病原体鉴定、血清型鉴定、耐药性和毒力鉴定。近年来,沙门氏菌检测技术突飞猛进,尤其是新兴分子检测技术的出现和发展,为不同场景下的沙门氏菌检测提供了新的视角。然而,由于沙门氏菌血清型的多样性和检测场景的复杂性,现有检测技术仍存在一些痛点(如检测时间长、操作步骤繁琐、场景适应性低等)。本文将阐述CRISPR Cas技术、数字PCR技术、测序技术、微流控技术等几种各具特色的新兴分子检测技术在沙门氏菌检测中的应用。旨在为发展和完善沙门氏菌检测技术、建立感染预警和控制系统提供参考。
{"title":"[The application and reflection of emerging molecular detection technologies in <i>Salmonella</i> detection].","authors":"L L Xiao, Y L Long, X J Qin, X Wang, Q L Dong","doi":"10.3760/cma.j.cn112150-20240227-00155","DOIUrl":"10.3760/cma.j.cn112150-20240227-00155","url":null,"abstract":"<p><p><i>Salmonella</i> is an important foodborne pathogen and one of the main causes of diarrhea. Every year, about 550 million people suffer from diarrhea due to <i>Salmonella</i> infection, of which about 230 000 die. It has become a major global public safety issue. The application fields of <i>Salmonella</i> detection involve food safety, water quality monitoring, animal husbandry, public health monitoring, and medical diagnosis. The detection requirements mainly come from three aspects: pathogen identification, serotype identification, drug resistance and virulence identification. In recent years, the detection technology for <i>Salmonella</i> has made rapid progress, especially the emergence and development of emerging molecular detection technologies, providing new perspectives for <i>Salmonella</i> detection in different scenarios. However, due to the diversity of <i>Salmonella</i> serotypes and the complexity of detection scenarios, existing detection technologies still have some pain points (such as long detection time, cumbersome operation steps, low scene adaptability, etc.). This article will elaborate on the application of several emerging molecular detection technologies with distinct characteristics, such as CRISPR Cas technology, digital PCR technology, sequencing technology, and microfluidic technology, in <i>Salmonella</i> detection. It aims to provide a reference for the development and improvement of <i>Salmonella</i> detection technology and the establishment of infection warning and control systems.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华预防医学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1